Baxter stock tumbled Tuesday, undercutting its 50-day line, after the medtech company agreed to sell its kidney segment to Carlyle for $3.8 billion. Please watch the video at Investors.com - How ...
Baxter International has agreed to sell its kidney treatment division to private equity firm Carlyle Group in a $3.8 billion cash deal, continuing its efforts to streamline its operations and ...
Baxter International has increased allocations for two U.S. IV solutions to 100% following the disruption caused by Hurricane Helene at its North Cove, N.C., facility, according to a letter to ...
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion ...
The company, a major provider of fluids used for home dialysis, is aiming to “restore ... units will be imported over the coming weeks as Baxter and federal agencies try to keep hospitals ...